PROSTATE CANCER AND PROSTATIC DISEASES
Scope & Guideline
Exploring breakthroughs in oncology and urology.
Introduction
Aims and Scopes
- Clinical Management and Treatment Strategies:
The journal emphasizes research on various treatment modalities for prostate cancer, including surgical techniques, radiation therapy, and hormonal treatments, aimed at improving clinical outcomes and patient quality of life. - Diagnostic Innovations:
There is a strong focus on the development and validation of diagnostic tools, such as imaging techniques (e.g., MRI, PSMA PET) and biomarkers, which are crucial for early detection and accurate staging of prostate cancer. - Patient-Centered Research:
The journal highlights studies that address patient experiences, decision-making processes, and the psychosocial aspects of prostate cancer treatment, emphasizing the importance of patient-reported outcomes. - Epidemiology and Health Disparities:
Research addressing the epidemiology of prostate cancer, including risk factors, health disparities among different populations, and the impact of socioeconomic factors on treatment access and outcomes, is a key area of interest. - Translational Research and Precision Medicine:
The journal supports studies that bridge laboratory research and clinical application, focusing on personalized medicine approaches, genetic profiling, and the role of molecular markers in treatment response. - Multidisciplinary Approaches:
The journal encourages collaborative research that integrates insights from urology, oncology, radiology, pathology, and other disciplines to advance comprehensive care strategies for prostate cancer patients.
Trending and Emerging
- Advanced Imaging Techniques:
There is a growing emphasis on the use of advanced imaging modalities, such as multiparametric MRI and PSMA PET scans, for the detection, staging, and monitoring of prostate cancer, reflecting technological advancements in diagnostics. - Biomarker Development and Precision Oncology:
Research focused on the identification and validation of biomarkers for prostate cancer prognosis and treatment response is on the rise, highlighting the trend towards precision medicine and individualized treatment strategies. - Health Disparities and Societal Impact:
Emerging studies addressing health disparities in prostate cancer incidence, treatment access, and outcomes among different racial and ethnic groups indicate a growing awareness of the social determinants of health. - Integration of Artificial Intelligence in Diagnostics:
The application of artificial intelligence and machine learning in improving diagnostic accuracy and treatment planning for prostate cancer is a rapidly emerging area, reflecting the increasing intersection of technology and healthcare. - Holistic and Multidisciplinary Care Approaches:
There is a trend towards research that emphasizes holistic care, integrating psychological support, lifestyle interventions, and patient education into the management of prostate cancer, indicating a shift to more comprehensive patient care models.
Declining or Waning
- Traditional Surgical Techniques:
There has been a noticeable reduction in publications focused solely on traditional surgical techniques for prostate cancer, as newer minimally invasive and robotic-assisted approaches gain traction and research emphasis. - Basic Science and Laboratory Studies:
Research articles centered on basic science and laboratory studies without direct clinical application have seen decreased representation, possibly due to a shift towards translational research that directly impacts patient care. - General Population Studies:
Publications investigating general population trends in prostate cancer incidence and treatment have declined, suggesting a shift towards more targeted studies that focus on specific populations or high-risk groups. - Historical Treatment Approaches:
As new therapies and methodologies emerge, there is less emphasis on historical treatment approaches that have been largely supplanted by more effective options, leading to fewer studies in this area. - Non-Oncological Prostate Conditions:
Research on benign prostatic hyperplasia and other non-cancerous prostate conditions appears to be waning, as the journal increasingly prioritizes studies that focus on prostate cancer and oncological outcomes.
Similar Journals
Urologia Journal
Elevating Urology: Insights and Innovations.Urologia Journal, with ISSN 0391-5603 and E-ISSN 1724-6075, is a pivotal publication in the field of urology, published by SAGE Publications Ltd. Established in the United States, the journal has a rich historical foundation, with coverage spanning various periods beginning in 1947 and continuing to the present day, indicating its commitment to chronicling advancements in urological research and practice. As of 2023, the journal has achieved a respectable Q3 ranking in the field of Urology, reflecting its increasing influence and relevance among academic peers. Though not an open-access journal, it provides substantial value to its readers with rigorous peer-reviewed content that enhances the understanding and treatment of urological conditions. Researchers, clinicians, and students are encouraged to engage with the Urologia Journal to keep abreast of the latest findings and methodologies that contribute to better patient care and innovative therapeutic options in urology. As the field evolves, Urologia Journal remains committed to promoting quality scholarship and disseminating vital knowledge that shapes the future of urology.
BMC Urology
Pioneering Research in Urology and Reproductive MedicineBMC Urology is a premier open-access journal dedicated to advancing research in the field of urology, reproductive medicine, and miscellaneous aspects of medicine. Published by BMC since 2001 and based in the United Kingdom, this journal provides a platform for researchers, clinicians, and students to disseminate their findings and explore the latest innovations and advancements within these vital fields. With a notable impact factor and categorization in the Q2 quartile for various categories of medicine, BMC Urology stands as a reputable source, ranking 51st out of 120 in Urology and 44th out of 90 in Reproductive Medicine according to Scopus metrics. The journal fosters knowledge sharing through its open-access model, ensuring that research is accessible to all. As it converges from 2001 to 2024, BMC Urology continues to play a crucial role in shaping the landscape of urological research and providing invaluable insights into clinical practices.
Current Urology
Empowering Research, Enhancing Patient CareCurrent Urology, published by Lippincott Williams & Wilkins, is a leading journal dedicated to advancing the fields of urology, oncology, and reproductive medicine. With an ISSN of 1661-7649 and E-ISSN of 1661-7657, this journal has established itself as a valuable resource for researchers, practitioners, and students alike, providing peer-reviewed articles that contribute to the ongoing discourse and development of these critical specialties. Operating out of the United States, Current Urology ranks in the third quartile for oncology, reproductive medicine, and urology, reflecting its importance in the medical community. The journal’s focus on innovative research and clinical practice allows it to bridge gaps between theoretical understanding and practical application, enhancing patient care and outcomes. Although currently not an open-access journal, it offers a wealth of insights and findings that underpin contemporary urological practices and research. In an evolving medical landscape, Current Urology remains an essential platform for disseminating knowledge and fostering collaboration among experts in the field.
Advances in Radiation Oncology
Innovating Radiotherapy for Better Patient OutcomesAdvances in Radiation Oncology, published by Elsevier Inc, is a premier international journal dedicated to the field of oncology and radiology, focusing on the latest groundbreaking research and innovations in radiation therapy. Launched as an Open Access journal in 2016, it has since carved out a significant niche in the academic community, featuring contributions that span a diverse range of topics including clinical practices, technologies, and outcomes in radiation oncology. With an impressive Q2 rankingOncology and Radiology, Nuclear Medicine and Imaging categories for 2023, and positioned within the 65th and 55th percentiles of Scopus ranks, it serves as an essential resource for researchers, medical professionals, and students alike. The journal not only emphasizes the importance of disseminating knowledge widely through its open access model but also aims to foster collaboration and innovation in the evolving landscape of cancer treatment. For those looking to stay at the forefront of radiotherapy research and advancements, Advances in Radiation Oncology is an invaluable platform for scholarly communication.
Radiation Oncology
Elevating oncology knowledge for better patient outcomes.Radiation Oncology is a premier scholarly journal published by BMC, dedicated to advancing the field of oncology through innovative research and comprehensive reviews since its inception in 2005. With its Open Access model, the journal ensures that the latest findings in radiotherapy and cancer treatment are accessible to a global audience, fostering collaboration and knowledge sharing among researchers, clinicians, and healthcare professionals. The journal has garnered an impressive reputation with prestigious rankings, achieving Q1 status in Radiology, Nuclear Medicine and Imaging and Q2 in Oncology as of 2023, reflecting its significant impact on the scientific community. In the Scopus rankings, it stands proud at Rank #61 in Radiology, Nuclear Medicine and Imaging, placing it in the top 81st percentile, and Rank #112 in Oncology at the 72nd percentile. With a converged publication plan extending through 2024, Radiation Oncology remains a vital resource for those dedicated to enhancing cancer treatment methodologies and outcomes.
Actas Urologicas Espanolas
Connecting Research and Practice in UrologyActas Urologicas Espanolas is a prestigious journal published by Elsevier España, dedicated to the field of Urology. Established in 1977, this journal has significantly contributed to advancing knowledge and research in urological medicine and surgery, spanning a comprehensive scope that includes clinical studies, surgical techniques, and the latest innovations in the treatment of urological diseases. With an impact factor reflecting its critical role in the academic community, it is ranked Q3 in the Urology category as of 2023, placing it amongst the valuable resources for professionals and researchers. The journal is indexed under Scopus, achieving a commendable rank of #70 out of 120 in the Medicine-Urology category, situating it within the 42nd percentile. As a significant platform for sharing advancements and findings, it encourages submissions that enhance urological care and improve patient outcomes. Although not an Open Access journal, the publication remains vital for those looking to stay updated on the latest developments in urology. For more details, visit their office located at CALLE DE ZURBANO, 76-4TH FLR LEFT, MADRID, 28010, SPAIN.
LANCET ONCOLOGY
Discovering innovative solutions for complex oncology challenges.The Lancet Oncology is a premier peer-reviewed journal published by Elsevier Science Inc., recognized as a leading authority in the field of oncology. With an ISSN of 1470-2045 and E-ISSN 1474-5488, this esteemed journal boasts an impressive 2023 impact factor placing it in the Q1 category of oncology—reflecting its role as a critical resource for cutting-edge research. The journal publishes high-quality articles covering novel scientific discoveries, clinical advancements, and public health issues related to cancer treatment and prevention. It is ranked #5 out of 404 in the Scopus Medicine _ Oncology category, demonstrating its influence and relevance in the field, with an outstanding rank in the 98th percentile. Operating from its base in the United Kingdom, The Lancet Oncology spans a comprehensive timeframe from 2000 to 2024, making it a vital repository of oncology literature. Although it does not primarily operate on an open-access model, its significant subscription base ensures that a wealth of knowledge is accessible to researchers, professionals, and students alike, fostering a profound understanding and advancement in oncology.
Breast Journal
Championing open access to vital breast health research.The Breast Journal, published by Wiley-Hindawi, is a distinguished Open Access journal dedicated to the fields of internal medicine, oncology, and surgery with a particular focus on breast health and disease. Since its inception in 1995, the journal has become an essential resource for researchers and clinicians, facilitating the dissemination of high-quality research and innovative clinical practices. With an impact factor reflecting robust scholarly influence and a ranking in the Q3 quartile for both internal medicine and oncology, as well as Q2 in surgery, it showcases significant contributions that advance knowledge and improve patient outcomes. Offering unparalleled access to its articles, The Breast Journal aims to support a global audience in exploring the multifaceted challenges and breakthroughs in breast-related health, making it a vital platform for shared learning and scientific discourse.
World Journal of Mens Health
Connecting research and practice for optimal men's health.World Journal of Men's Health, published by the Korean Society for Sexual Medicine and Andrology, stands at the forefront of research in urology, reproductive medicine, and public health. This open-access journal, which has been serving the global medical community since 2011, provides a platform for high-quality, peer-reviewed articles spanning various disciplines, including aging, health policy, and pharmacology. With impressive rankings in multiple categories—such as Q1 in Urology and Q2 in Reproductive Medicine—the journal is recognized for its impactful contributions to advancing knowledge and practice. The ISSN 2287-4208 and E-ISSN 2287-4690 ensure its broad visibility and accessibility. The journal's commitment to disseminating vital research findings makes it an essential resource for researchers, practitioners, and students dedicated to improving men's health worldwide. With its editorial office located at Pusan National University Medical School, Dept of Urology, Busan, South Korea, it continues to enrich the academic and clinical landscape.
Prostate International
Transforming urological practices with cutting-edge findings.Prostate International is a leading open-access journal published by Elsevier Inc, dedicated to advancing research and knowledge in the field of urology, particularly focusing on prostate health and disease. Since its inception in 2013, the journal has preserved its commitment to disseminating high-quality, peer-reviewed articles that contribute significantly to clinical practices and scientific understanding. With an impressive Q1 ranking in urology and a current position as rank #35/120 among urology journals in Scopus, it occupies a prominent place in the academic landscape, ensuring that cutting-edge research reaches a broad audience. The journal's open-access policy enhances visibility and accessibility, fostering collaboration among researchers, healthcare professionals, and students. With the range of topics covered, from innovative treatments to diagnostic advancements, Prostate International serves as a vital resource for those committed to improving patient outcomes and driving the future of urological health.